TY - JOUR
T1 - Effects of inhibition of fatty acid oxidation on myocardial kinetics of 11C-labeled palmitate
AU - Wyns, W.
AU - Schwaiger, M.
AU - Huang, S. C.
AU - Buxton, D. B.
AU - Hansen, H.
AU - Selin, C.
AU - Keen, R.
AU - Phelps, M. E.
AU - Schelbert, H. R.
PY - 1989
Y1 - 1989
N2 - The effects of glucose and lactate infusion on palmitate oxidation were compared with the effect of 2-tetradecylglycidic acid (TDGA), an irreversible inhibitor of the carnitine acyltransferase I, in normoxic canine myocardium. The initial capillary transit retention fraction of [1-11C]palmitate and its fractional distribution between oxidation and esterification in myocardium were measured by the residue detection method after intracoronary tracer injection, as well as by effluent measurements of 12CO2, the end product of palmitate oxidation. TDGA reduced the initial capillary transit retention fraction (From 56 ± 13% to 37 ± 6%; p < 0.001) and oxidation of palmitate (n = 19), as also evidenced by the decrease in the fraction of tracer released as 11CO2 from 28 ± 5% to 6 ± 3% (p < 0.001). Infusion of carbohydrate (glucose or lactate; n = 6) reduced 11CO2 production from 30 ± 7% to 7 ± 4% (p < 0.05) but did not alter the initial capillary transit retention fraction of tracer (59 ± 5% vs. 56 ± 10%; NS). The latter was due to increased esterification into neutral ipids (41 ± 11% of injected palmitate after carbohydrate infusion versus 21 ± 12% in control conditions), as measured from multiexponential curve fittings. When carbohydrates were given after inhibition of palmitate oxidation by TDGA (n = 7), the 11C tissue clearance kinetics were strikingly similar to those observed after carbohydrate infusion alone. Thus, enhanced metabolic trapping of [1-11C]palmitate in myocardium resulted in initial capillary transit retention fractions that were not different from control conditions (41 ± 5% vs. 48 ± 12%; NS) despite inhibition of oxidation. The results show that the intracellular metabolism of palmitate contributes to the control of its uptake by myocardium. The findings are consistent with inhibition of palmitate oxidation by carbohydrates occurring at the same site as TDGA.
AB - The effects of glucose and lactate infusion on palmitate oxidation were compared with the effect of 2-tetradecylglycidic acid (TDGA), an irreversible inhibitor of the carnitine acyltransferase I, in normoxic canine myocardium. The initial capillary transit retention fraction of [1-11C]palmitate and its fractional distribution between oxidation and esterification in myocardium were measured by the residue detection method after intracoronary tracer injection, as well as by effluent measurements of 12CO2, the end product of palmitate oxidation. TDGA reduced the initial capillary transit retention fraction (From 56 ± 13% to 37 ± 6%; p < 0.001) and oxidation of palmitate (n = 19), as also evidenced by the decrease in the fraction of tracer released as 11CO2 from 28 ± 5% to 6 ± 3% (p < 0.001). Infusion of carbohydrate (glucose or lactate; n = 6) reduced 11CO2 production from 30 ± 7% to 7 ± 4% (p < 0.05) but did not alter the initial capillary transit retention fraction of tracer (59 ± 5% vs. 56 ± 10%; NS). The latter was due to increased esterification into neutral ipids (41 ± 11% of injected palmitate after carbohydrate infusion versus 21 ± 12% in control conditions), as measured from multiexponential curve fittings. When carbohydrates were given after inhibition of palmitate oxidation by TDGA (n = 7), the 11C tissue clearance kinetics were strikingly similar to those observed after carbohydrate infusion alone. Thus, enhanced metabolic trapping of [1-11C]palmitate in myocardium resulted in initial capillary transit retention fractions that were not different from control conditions (41 ± 5% vs. 48 ± 12%; NS) despite inhibition of oxidation. The results show that the intracellular metabolism of palmitate contributes to the control of its uptake by myocardium. The findings are consistent with inhibition of palmitate oxidation by carbohydrates occurring at the same site as TDGA.
KW - 2-tetradecylglycidic acid
KW - carbohydrate utilization
KW - carnitine palmitoyl transferase
KW - fatty acid metabolism
KW - normoxic canine myocardium
KW - positron emission tomography
UR - http://www.scopus.com/inward/record.url?scp=0024842186&partnerID=8YFLogxK
U2 - 10.1161/01.RES.65.6.1787
DO - 10.1161/01.RES.65.6.1787
M3 - Article
C2 - 2684448
AN - SCOPUS:0024842186
SN - 0009-7330
VL - 65
SP - 1787
EP - 1797
JO - Circulation Research
JF - Circulation Research
IS - 6
ER -